(1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)cyclohexane-1,3-diol; 22-Z-Paricalcitol; (1R,3R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-Octahydro-1-[(1R,2Z,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol; (1?,3?,7E,22Z)-19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol; (22Z)-19-Nor-1,25-dihydroxyvitamin D2; (22Z)-1?,25-Dihydroxy-19-nor-vitamin D2; (22Z)-Zemplar;22Z -Paricalcitol (USP)
22Z-Paricalcitol is a fully characterized chemical compound used as a reference standard of API Paricalcitol. The standard offered is compliant with regulatory guidelines. 22Z-Paricalcitol is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1884139-61-0
